Vaxcyte Inc (PCVX)

Cost of Revenue

$865.00K

TTM · Period ending: · USD

PCVX logo

PCVX Cost of Revenue

Latest reported$865.00K
PCVX TTM Cost of Revenue ($0.00 → $865.00K)
High-resolution chart · PNG

PCVX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vaxcyte Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
865,000
5,854,000
0
4,989,000
4,989,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.